Glanbia poised for growth through American acquisition

Glanbia poised for growth through American acquisition
Recipe for success Siobhan Talbot, Glanbia managing director, and Mark Garvey, financial director. Picture: Jason Clarke Photography

Glanbia is buoyant after another year of strong growth and can make more moves in the growing performance nutrition market, writes Michael Murray.

CytoSport, the US-based sports nutrition business, remains a potential takeover target for Glanbia as the bidding process for the US company remains a work in progress.

Following its results announcement last week Glanbia group managing director Siobhán Talbot said that any decision to raise new equity would be ''event driven. This followed reports - in circulation since last summer - that the performance nutrition and ingredients group is on a shortlist of potential buyers for...

Subscribe from just 1€

Exclusive offers

Choose the subscription that is right for you

Monthly Subscription

€1

For the first month

€19.99 Monthly Thereafter

Subscribe today

Cancel anytime

Annual Subscription

€200€149

For the first year

€199.99 annually thereafter

Subscribe today

Cancel anytime

Quarterly Subscription

€55€42

For the first 90 days

€55.00 quarterly Thereafter

Subscribe today

Cancel anytime

These offers are not available for current subscribers. Offers and pricing are subject to change without notice.

Terms & Conditions Apply

Please Subscribe or Log in to continue

Subscribe Login

More from The Business Post